Health Care & Life Sciences » Pharmaceuticals | Dongsung Pharmaceutical Co. Ltd.

Dongsung Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,988
10,947
455
1,660
198
5,745
Depreciation, Depletion & Amortization
1,465
1,542
1,609
1,573
1,741
1,915
Other Funds
40
58
300
52
21
5,018
Funds from Operations
202
2,547
7,970
2,521
3,868
1,188
Changes in Working Capital
2,833
1,047
1,302
5,873
2,049
205
Net Operating Cash Flow
2,631
3,594
9,272
3,352
1,819
1,393
Capital Expenditures
1,188
1,288
647
2,842
3,004
Sale of Fixed Assets & Businesses
23
-
72
5
11
Purchase/Sale of Investments
92
10,896
6,950
1,820
3,483
Net Investing Cash Flow
1,362
11,917
6,439
933
557
Cash Dividends Paid - Total
530
549
-
-
-
Issuance/Reduction of Debt, Net
536
1,400
1,568
2,405
966
Net Financing Cash Flow
1,537
7,957
226
2,457
988
Net Change in Cash
2,584
174
2,477
1,752
1,163
Free Cash Flow
3,713
2,330
9,900
6,084
802
Other Sources
981
725
63
263
686
Change in Capital Stock
1,491
7,164
1,494
-
-
Exchange Rate Effect
128
191
131
76
226
Other Uses
1,270
458
-
180
618

About Dongsung Pharmaceutical Co.

View Profile
Address
683 Dobong-ro
Seoul SL 01340
Korea, Republic Of
Employees -
Website http://www.dongsung-pharm.co.kr
Updated 07/08/2019
Dongsung Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceuticals. It operates through following business divisions: Pharmaceutical and Cosmetic. Its products include general and special medicines such anti-rheumatic and anti-inflammatory analgesics, anti-inflammatory enzymes, cardiovascular system, gastrintestinal drugs, antispasmodic agents, respiratory agents, anti-histamine, dematologicals, antibiotics, antidiarreals, antifungals, oral hypoglycemic agents, hormones and tranquillizers.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.